The 2024 GINA updates shift asthma management from reactive to proactive, taking a more holistic approach that is consistent with other chronic diseases, aiming to improve long-term outcomes. ICS-containing inhalers are now recommended for both reliever and maintenance therapy, emphasizing the need for simplifying treatment regimens.
Read More
New Endocrine Society guidelines provide updated recommendations for vitamin D testing and supplementation. Screening tests are not cost-effective but supplementation may be beneficial in several patient populations.
Read More
There are nearly 100,000 mobile health apps but only a tiny fraction are evaluated by the FDA. As the use of mobile health apps grows, it is important to identify apps with evidence of safety, accuracy, and effectiveness.
Read More
The Evidence-Based Literature Evaluation Series will be available for BCGP recertification credit through the American Pharmacists Association – Coming April 2024!
Read More
Vasomotor symptoms (hot flashes) negatively impact quality of life and sleep. Not all women are eligible for or want to use hormonal therapy. The North American Menopause Society (NAMS) provides an evidence-based review of the non-hormonal alternatives.
Read More
Older adults taking antihyperglycemics are inherently at a higher risk for hypoglycemia but studies suggest that many patients with complex medical problems and in poor health are being overtreated.
Read More
In 2023, a targeted update to the American Geriatric Society (AGS) Beers Criteria was published, including a few additions, several removals, and some notable revisions.
Read More
Hoarding and the improper disposal of unused antibiotics are serious problems with significant consequences.
Read More
Fasting is an important component of Ramadan for Muslims. A majority of patients with diabetes choose to fast. Pharmacists can play a vital role in helping patients to safely fast.
Read More
The number of cases of monkeypox has increased rapidly over the past month and a national health emergency was declared. But effective vaccinations and treatments are available.
Read More
The American Gastroenterological Association recently released best practice recommendations for deprescribing PPIs.
Read More
Two oral agents have been given emergency authorization to treat mild-moderate COVID-19 infection in patients at high risk of hospitalization or death.
Read More
iForumRx.org is a web-based community of practice designed to inform ambulatory care pharmacy specialists, pharmacy residents, and student pharmacists about high-quality, practice-changing evidence.
Loading ...